Large-scale testing (Phase 3)Ended earlyNCT00486213
What this trial is testing
Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
Who this might be right for
Dermatologic ComplicationsPalmar-plantar ErythrodysesthesiaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Centre, Singapore 210